- Describe new findings in differential diagnosis and treatment of various diseases;
- Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
- Identify cost-effective treatment regimens;
- Explain the advantages and disadvantages of new disease screening procedures.
Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Relias LLC designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. This Enduring Material activity, Internal Medicine Alert, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 1/15/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 2 AAFP Prescribed credits. The American Osteopathic Association has approved this continuing education activity for up to 2 AOA Category 2-B credits. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Salix, Allergan, Janssen, Lilly, Novo Nordisk, and Sanofi; he serves on the speakers bureau of Salix, Allergan, Janssen, Lilly, Sanofi, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim. Peer Reviewer Gerald Roberts, MD; Editor Jonathan Springston; Executive Editor Leslie Coplin; and Editorial Group Manager Terrey L. Hatcher report no financial relationships relevant to this field of study.